ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,729, issued on Oct. 28, was assigned to AstraZeneca AB (Sodertalje, Sweden).
"Pharmaceutical formulations" was invented by Farhan Abdel Karim Mohammad Al Husban (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present specification relates to pharmaceutical formulations comprising N-(1-(3-fluoropropyl)azetidin-3-yl)-6-((6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)pyridin-3-amine, microcrystalline cellulose (MCC) and dicalcium phosphate anhydrous (DCPA), for example tablets with immediate release properties."
The patent was filed on April 22, 2021, under Application No. 1...